The latest breakthrough in schizophrenia treatment is Cobenfy (xanomeline-trospium), the first new class of antipsychotic approved in decades, targeting cholinergic receptors instead of dopamine, potentially reducing side effects like weight gain and drowsiness, alongside ongoing research into GLP-1 agonists for weight management, smarter therapies, and novel formulations like once-weekly pills.
The drug, from Bristol Meyers Squibb, is called Cobenfy™ (previously known as KarXT), and it was approved by the Food and Drug Administration (FDA) in September 2024. Cobenfy uses a different mechanism of action than previous drugs for schizophrenia.
According to the American Psychiatric Association, second-generation (atypical) antipsychotics (SGAs)—with the exception of clozapine—are the agents of choice for first-line treatment of schizophrenia.
Risperidone is a second-generation antipsychotic used to treat schizophrenia, schizoaffective disorder and other conditions. It works by altering the effects of certain chemicals in the brain, including dopamine and serotonin.
INDICATIONS
Despite mixed results found in literature, long-acting injectable antipsychotics (LAIs) should offer better efficacy and tolerability, compared to oral antipsychotics due to improved adherence and more stable pharmacokinetics.
Quetiapine fumarate, also known by the brand name Seroquel, is the most prescribed antipsychotic medication in the U.S., representing more than 28% of antipsychotic prescriptions. The medication is most often used to treat bipolar disorder and schizophrenia.
Medicines are the main schizophrenia treatment. Antipsychotic medicines are the most prescribed drugs. They're thought to control symptoms mainly by affecting brain receptors for different neurotransmitters, or chemical messengers. Most antipsychotic medications act on dopamine and serotonin receptors.
The "25 rule" (or "rule of quarters") in schizophrenia suggests that outcomes fall into four roughly equal groups: 25% recover fully, 25% improve significantly with some ongoing support, 25% improve somewhat but need considerable help, and 25% have a poor outcome with chronic illness or suicide risk, highlighting the varied nature of schizophrenia's long-term course, though some sources use a "rule of thirds" with similar proportions for different outcomes.
Clozapine is often the last resort for people with schizophrenia who haven't responded to other medications. For many, it is life-changing – reducing symptoms, hospitalisations, and even suicide risk.
Research suggests a combination of physical, genetic, psychological and environmental factors can make a person more likely to develop the condition. Some people may be prone to schizophrenia, and a stressful or emotional life event might trigger a psychotic episode.
Sweden is known for its comprehensive mental health services and a strong commitment to providing quality care for individuals with schizophrenia. The country's healthcare system offers a range of treatment options, including psychotherapy and medication, and prioritizes early intervention.
Psychotherapy: Talk therapy, like cognitive behavioral therapy for psychosis (CBTp), may help you better understand how your thoughts influence your behaviors. It could help you reduce stress and learn healthy coping skills that may improve daily functioning and prevent complications.
Schizoaffective disorder is a mental health condition that is marked by a mix of schizophrenia symptoms, such as hallucinations and delusions, and mood disorder symptoms, such as depression, mania and a milder form of mania called hypomania.
Males reach a single peak of vulnerability for developing schizophrenia between the ages of 18 and 25 years. In contrast, female vulnerability peaks twice; first between 25 and 30 years, and then again around 40 years of age.
This can be a passive diversion, for example watching television, listening to music, using headphones or relaxation. Alternatively the distraction can involve activity such as playing an instrument, writing, reading, gardening, walking or any form of exercise.
Speech may be mildly disorganized or completely incoherent and incomprehensible. Disorganized (bizarre) behavior may take the form of childlike silliness, agitation, or inappropriate appearance, hygiene, or conduct.
Disability Ratings for Schizophrenia
100% disability rating: a 100% disability rating for this condition is assigned when the veteran suffers total occupational and social impairment.
Early diagnosis and appropriate treatment make it possible to recover from psychosis. Some people who receive early treatment never have another psychotic episode.
Someone with existing genetic risk factors for the disorder may develop an active case of schizophrenia after extended substance abuse. Using drugs, such as marijuana, cocaine and amphetamines, can also exacerbate schizophrenic symptoms and worsen their severity.
Schizophrenia is a mental illness that causes psychosis, but schizophrenia also has other symptoms. And it isn't the only cause of psychosis. In some cases, other mental illnesses cause psychosis, including depression, bipolar disorder, dementia and borderline personality disorder.
Atypical Antipsychotics
These medications, including quetiapine, risperidone, and aripiprazole, are generally prescribed because they pose a lower risk of certain serious side effects than conventional antipsychotics.
Clozapine, olanzapine, quetiapine and trifluoperazine are the most difficult to Taper.
Five constructs (the 5 “A”) were identified as negative symptoms namely affect (blunted), alogia, anhedonia, asociality, and avolition and were clustered into two factors: one including blunted affect and alogia and the other consisting of anhedonia, avolition, and asociality (Table 1).
Antidepressants that may be used for schizophrenia include: